Safety evaluation of colesevelam therapy to achieve glycemic and lipid goals in type 2 diabetes

Author： Avitabile Nicholas   Banka Ajaz   Fonseca Vivian A  

Publisher： Informa Healthcare

ISSN： 1474-0338

Source： Expert Opinion on Drug Safety, Vol.10, Iss.2, 2011-03, pp. : 305-310

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

An Economic Evaluation of Colesevelam when Added to Metformin-, Insulin- or Sulfonylurea-Based Therapies in Patients with Uncontrolled Type 2 Diabetes Mellitus

By Simons W. Robert   Hagan Michael A.  

PharmacoEconomics, Vol. 28, Iss. 9, 2010-09 ,pp. : 765-780

Adis International

Access to resources Recommend Favorite

Combination lipid therapy in type 2 diabetes mellitus

By Vergèès Bruno  

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 9, 2011-06 ,pp. : 1393-1403

Informa Healthcare

Access to resources Recommend Favorite

Individualized selection of insulin therapy helps achieve glycaemic control in type 1 or type 2 diabetes mellitus

By Adis International Limited  

Drugs & Therapy Perspectives, Vol. 24, Iss. 5, 2008-05 ,pp. : 13-16

Adis International

Access to resources Recommend Favorite

Colesevelam valuable adjunct in lipid-lowering therapy

By  

Inpharma, Vol. 1, Iss. 1285, 2001-01 ,pp. : 15-16

Adis International

Access to resources Recommend Favorite

Mechanisms, Significance and Treatment of Vascular Dysfunction in Type 2 Diabetes Mellitus: Focus on Lipid-Regulating Therapy

By Woodman Richard J.   Chew Gerard T.   Watts Gerald F.  

Drugs, Vol. 65, Iss. 1, 2005-01 ,pp. : 31-74

Adis International

Access to resources Recommend Favorite